Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Angus Liu
DEPUTY EDITOR, FIERCE PHARMA
Forging Biotech Alliances in China
Are We Past the Checkpoint?
Washington, DC, District of Columbia, United States
Sarah Lively, PhD
SENIOR DIRECTOR, EXTERNAL INNOVATION, DISCOVERY, PRODUCT DEVELOPMENT & SUPPLY, JOHNSON & JOHNSON
Don't Be Afraid of the Dark Genome: New Therapies from Regulatory Non-Coding RNA
David Lloyd, ACA
MANAGING DIRECTOR, SOUTHERN STAR RESEARCH
Australia
Sydney, New South Wales, Australia
Placeholder Photo
Kenneth Locke, PhD
CSO, SHANGHAI PHARMA BIOTHERAPEUTICS USA INC
Shanghai Pharmaceuticals Holding Co., Ltd
San Diego, United States
Brad Loncar
CEO, LONCAR INVESTMENTS
Biotech Hangout
Roger Longman
FOUNDER AND CHAIRMAN, REAL ENDPOINTS
Case Study: Launching Successful Gene Therapies in the Value-Based Era
Scaling Approved Patient-Centered Therapies: Resolving the Diagnostic Challenge
Prescient Diagnostics: Implications for Product Development and Reimbursement
Westport, Connecticut, United States
David Longo, MS
CEO, ORDAOS
Ordaos Bio
New York, New York, United States
Glaudina Loots
DIRECTOR, HEALTH INNOVATION, DEPARTMENT OF SCIENCE AND INNOVATION, SOUTH AFRICA
Vaccine Manufacturing in Africa: Challenges and Opportunities
Angelica Loskog, PhD
CEO, LOKON PHARMA
Lokon Pharma
Uppsala, Uppsala Lan, Sweden
Ted Love, MD
CHAIR, BIO BOARD OF DIRECTORS
Planning for the Future: Building Inclusive Corporate Boards